Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung carcinomas
- 11 February 2002
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 196 (4) , 408-415
Abstract
The pathogenesis and interrelationships of neuroendocrine lung carcinomas are not well understood. Tissue macro‐arrays prepared from surgical resection specimens from 35 patients with typical carcinoid (TC), six with atypical carcinoid (AC), 13 with large cell neuroendocrine carcinoma (LCNEC), and 15 with small cell lung carcinoma (SCLC) were investigated by fluorescence in situ hybridization (FISH) and immunohistochemistry. Hybridizations with locus‐specific DNA probes demonstrated a high incidence of deletion for the tumour suppressor genes p53 and retinoblastoma (Rb), and for the oncogene cyclin D1, comparable in all carcinoma types. Similarly, an increase of DNA copy number for the Her‐2/neu and c‐myc oncogenes was noted in all neoplasms. A more detailed quantitative analysis of the results, however, demonstrated increasing numbers of cells harbouring these genomic alterations, from low‐grade TC to highly malignant SCLC, with the exception of cyclin D1 deletion. Mutations of the p53 and Rb genes, as assayed by immunohistochemical studies, were observed at high incidence in high‐grade carcinomas, compared with a low incidence in the low‐grade carcinomas. Conversely, in all carcinoma types, neither membrane‐bound Her‐2/neu nor nuclear cyclin D1 was detected. It is concluded that structural genomic alterations are frequent in neuroendocrine lung carcinomas and that their occurrence may be underestimated by immunohistochemical studies alone. The quantitative expansion of the Rb, p53, c‐myc, and Her‐2/neu alterations towards high‐grade carcinomas suggests common pathogenetic mechanisms in the spectrum of these neoplasms. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 16 references indexed in Scilit:
- Genetic changes in the spectrum of neuroendocrine lung tumorsCancer, 1999
- Histological Typing of Lung and Pleural Tumours1999
- Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumorsCancer, 1998
- Common patterns of genetic evolution in human solid tumorsCytometry, 1997
- Detection of aneuploidy in interphase nuclei from non-small cell lung carcinomas by fluorescence in situ hybridization using chromosome-specific repetitive DNA probesCancer Genetics and Cytogenetics, 1996
- Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancerBritish Journal of Cancer, 1996
- Overexpression of the tumour suppressor gene p53 is not implicated in neuroendocrine tumour carcinogenesisThe Journal of Pathology, 1995
- Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuro‐endocrine lung carcinomasInternational Journal of Cancer, 1994
- Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer.Proceedings of the National Academy of Sciences, 1994
- In situ hybridization techniques for the analysis of gene expression: Applications in tumor pathologyHuman Pathology, 1994